10x Genomics (TXG) Enterprise Value (2019 - 2026)

10x Genomics has disclosed Enterprise Value across 8 years of filings, most recently posting $4.4 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 347.08% year-over-year to $4.4 billion; the TTM figure through Jun 2026 stood at $4.4 billion (up 347.08% YoY), while the FY2025 annual figure was $1.6 billion, up 14.42% from the prior year.
• Enterprise Value came in at $4.4 billion for Q2 2026 at 10x Genomics, up from $2.2 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $8.1 billion in Q1 2022 to a low of $648.1 million in Q1 2025.
• Average Enterprise Value over 5 years is $3.5 billion, with a median of $3.3 billion recorded in 2022.
• Year-over-year, Enterprise Value tumbled 84.27% in 2025 and surged 347.08% in 2026.
• Over 5 years, Enterprise Value stood at $3.8 billion in 2022, then surged by 66.57% to $6.3 billion in 2023, then sank by 78.29% to $1.4 billion in 2024, then grew by 14.42% to $1.6 billion in 2025, then soared by 184.95% to $4.4 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $4.4 billion in Q2 2026, $2.2 billion in Q1 2026, and $1.6 billion in Q4 2025.